Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
Johann Bauersachs(Medizinische Hochschule Hannover), Karen Sliwa(University of Cape Town), Mark C. Petrie(British Heart Foundation), Piotr Ponikowski(Wroclaw Medical University), Righab Hamdan(Orient-Institut Beirut), Rudolf A. de Boer(Erasmus MC), Amam Mbakwem(University of Lagos), Alice M. Jackson(University of Glasgow), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Alexander R. Lyon(Royal Brompton Hospital), Stéphane Heymans(Maastricht University Medical Centre), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Lars H. Lund(Karolinska University Hospital), Petar Seferović, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Paul Forsyth(University of Glasgow), Massimo Piepoli(University of Milan), Tobias König(Medizinische Hochschule Hannover), Peter van der Meer(University Medical Center Groningen), Mark R. Johnson(Chelsea and Westminster Hospital NHS Foundation Trust), Christian Mueller(Immutep (Germany)), Stefan D. Anker(Bayer (Germany))
Cited by 435
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k